As medicine advances to employ sophisticated anticancer agents to treat a vast array of
oncological conditions, it is worth considering side effects associated with several …

In recent years, the development of more effective drugs has provided a better prognosis
and an increase in life expectancy for patients at all-stages of cancer. On the other hand, the …

As cancer therapeutics continues to improve and progress, the adverse side effects
associated with anticancer treatments have also attracted more attention and have become …

Tremendous strides have been made in the treatment of various oncological diseases such
that patients are surviving longer and are having better quality of life. However, the success …

Along with the remarkable progress registered in oncological treatment that led to increased
survival of cancer patients, treatment-related comorbidities have also become an issue for …

Cardiotoxic effects of chemotherapy and targeted drugs are ubiquitous and challenging in
the field of oncology therapeutics. The broad spectrum of toxicities ranging from ischemic …

Chemotherapy is a main treatment for cancer, and it benefits patients by controlling cancer
relapse and metastasis, thereby leading to an increase in the overall survival rate. However …

Several anticancer agents are associated with significant cardiotoxicity. The list of
cardiotoxic cancer therapeutic agents includes anthracyclines, trastuzumab, alkylating …

With the improvement in cancer survival, long-term cardiotoxicity has become an area of
increased interest. Various cancer therapies, including chemotherapy and radiation therapy …

Cardiotoxicity is a common complication of many anti-cancer agents and it remains a major
limitation, strongly impacting the quality of life and the overall survival, regardless of the …